Summary:
A randomized, Double-blind, Placebo Controlled, Phase 3 Trial to evaluate the efficacy and Safety of Study Drug for the treatment of Moderate to Severe Vasomotor symptoms in Postmenopausal Women.
Qualified Participants Must:
Postmenopausal women
40 -65 years of age seeking treatment for relief of moderate to severe vasomotor symptoms (hot flashes)
able and willing to complete daily paper diaries
Be willing to have an endometiral biopsy
English or Spanish speaking
Qualified Participants May Receive:
Study medication and evaluations by board certified physicians and study coordinators; Compensation for time and travel